Will Atrion Corporation (NASDAQ:ATRI) Run Out of Steam Soon? Short Interest is Up

October 2, 2018 - By Michael Collier

Investors sentiment increased to 1.4 in 2018 Q2. Its up 0.10, from 1.3 in 2018Q1. It increased, as 8 investors sold Atrion Corporation shares while 35 reduced holdings. 21 funds opened positions while 39 raised stakes. 1.06 million shares or 1.48% less from 1.07 million shares in 2018Q1 were reported.
Bnp Paribas Arbitrage Sa invested 0% in Atrion Corporation (NASDAQ:ATRI). National Bank & Trust Of Montreal Can reported 0% in Atrion Corporation (NASDAQ:ATRI). Manufacturers Life Insur Com The invested in 1,045 shares. Livingston Grp Asset Mgmt (Operating As Southport Cap Management) holds 460 shares or 0.12% of its portfolio. First Quadrant Ltd Partnership Ca holds 0.01% or 737 shares in its portfolio. 1,033 were reported by Schroder Investment Management Group. Redmond Asset Mngmt Llc invested in 1,585 shares. Wells Fargo Commerce Mn stated it has 0% of its portfolio in Atrion Corporation (NASDAQ:ATRI). Martingale Asset Mgmt L P has 4,700 shares for 0.03% of their portfolio. Susquehanna Intll Grp Incorporated Llp has 1,854 shares for 0% of their portfolio. Pnc Fincl Svcs Gp has invested 0% in Atrion Corporation (NASDAQ:ATRI). State Street holds 0% of its portfolio in Atrion Corporation (NASDAQ:ATRI) for 38,077 shares. Morgan Stanley holds 4,204 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Management invested in 400 shares or 0% of the stock. Goldman Sachs Grp Inc has 2,035 shares for 0% of their portfolio.

The stock of Atrion Corporation (NASDAQ:ATRI) registered an increase of 10.37% in short interest. ATRI’s total short interest was 18,100 shares in October as published by FINRA. Its up 10.37% from 16,400 shares, reported previously. With 3,600 shares average volume, it will take short sellers 5 days to cover their ATRI’s short positions. The short interest to Atrion Corporation’s float is 1.28%.

The stock increased 0.15% or $1 during the last trading session, reaching $680. About 2,819 shares traded. Atrion Corporation (NASDAQ:ATRI) has declined 4.20% since October 2, 2017 and is downtrending. It has underperformed by 19.82% the S&P500.

Atrion Corporation develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products worldwide. The company has market cap of $1.26 billion. The companyÂ’s fluid delivery products include valves that promote infection control and needle safety, as well as for use in intubation, intravenous, catheter, and other applications in the fields of anesthesia and oncology. It has a 37.24 P/E ratio. The Company’s cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery.

Atrion Corporation (NASDAQ:ATRI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: